All Stories

  1. Comparison of monocular video-based methods for measuring the amplitude of hand tremor
  2. Handwriting patterns in isolated rapid eye movement sleep behaviour disorder
  3. Strength of associations between regional brain volumes and dual decline in gait and memory
  4. A comprehensive review on deep supervision in computer vision
  5. Circadian dysregulation in probable isolated REM sleep behaviour disorder: actigraphy insights from the Tasmanian ISLAND Sleep Study
  6. Remote unsupervised tests of isolated REM sleep behaviour disorder in the community: results from the Tasmanian ISLAND Sleep Study
  7. Large-scale Visuomotor Reaction Time Self-Testing Reveals Subtle Motor Changes in Older Adults with Subjective Cognitive Impairment
  8. Tongue strength and cognitive decline in older adults: A scoping review
  9. Smartphone self-testing of hand and speech motor functions: a study of reliability and usability in older adults
  10. Parallel Multi-Scale Deep Supervision Net for Hand Key Point Detection
  11. Associations Between Regional Brain Volumes and Dual Decline in Gait Speed and Memory
  12. Evaluating the Impact on Clinician Diagnostic Confidence and Management Following Disclosure of Alzheimer's Disease Probability Informed by Plasma pTau181 Levels in Memory and Cognition Clinic Patients: A Before‐and‐After Study
  13. Investigating the contribution of tongue strength measurement in determining pre‐clinical Alzheimer's disease pathology in older adults
  14. New insights from combining gait and hand motor function in classification of amnestic MCI and Alzheimer's Disease
  15. Physical activity and blood‐based biomarkers of neurodegeneration in community dwelling Australians from ISLAND (Island Study Linking Ageing and Neurodegenerative Disease)
  16. A word in the hand is worth two in the push: Comparing vocal and manual responses to the arrow-word Stroop task
  17. Association of tongue, handgrip, and pinch strength with blood-based phosphorylated-tau 181 in cognitively healthy older adults
  18. Modifiable Dementia Risk Factors by Country of Birth among South Asian Migrants Aged 50 or Older in Tasmania, Australia
  19. Association of chronic pain and analgesic use with the risks of Parkinson’s and Alzheimer’s disease
  20. The Tasmania-London protocol to detect isolated rapid eye movement sleep behavior disorder using home-based video-polysomnography
  21. Advice to people with Parkinson's in my clinic: How to manage running-induced dystonia
  22. Gait in Older People with Cognitive Impairments During Rhythmic Auditory Cueing: A Scoping Review
  23. Chronic Pain in Parkinson’s Disease: Prevalence, Sex Differences, Regional Anatomy and Comorbidities
  24. Are We Asking the Right Questions? Sex Specificity of Dream Characteristics in Probable Rapid Eye Movement Sleep Behavior Disorder
  25. Evaluating the impact of human expertise in human-centered AI: A case study on finger-tapping video analysis for dementia detection
  26. Falls in people with Alzheimer’s disease: Exploring the role of inhibitory control
  27. Digitised hand movement and plasma NfL are complementary biomarkers of the dementia continuum
  28. Modifiable dementia risk factors by country of birth among South Asian migrants aged 50 or older in Tasmania, Australia
  29. A comparison of modifiable risk factors for dementia among South Asian migrants and non-migrants aged 50 or older in Tasmania, Australia
  30. Physical activity and blood‐based biomarkers of neurodegeneration in community dwelling Australians from ISLAND (Island Study Linking Ageing and Neurodegenerative Disease)
  31. Self-testing for symptoms and signs of prodromal alpha-synucleinopathies: results from the Tasmanian ISLAND Sleep Study
  32. Putting the patient first: Should general practitioners start people with probable Parkinson’s disease on levodopa while awaiting diagnostic confirmation?
  33. Rapid repetitive syllable sounds associate with episodic memory, executive function, and working memory in cognitively healthy and subjectively impaired older adults
  34. Presymptomatic blood tests to detect neurodegeneration: Perceptions of potential consumers across the life course
  35. The Tasmania-London (TASLON) 3-step home-based video-polysomnography approach to detect iRBD in the community: protocol and preliminary results
  36. Impact of Plasma pTau181 Levels on Clinician Diagnostic Confidence and Management in Memory and Cognition Clinics: A Multi-site Before-and-After Study
  37. Stepping and tapping: combining motor tasks improves cognitive classification
  38. Keeping an eye on Parkinson’s disease: color vision and outer retinal thickness as simple and non-invasive biomarkers
  39. Deep Learning Analysis of Figure Copying Tasks for Parkinson’s Disease Detection with GAN-Based Data Augmentation
  40. Post-diagnostic support in Australia: Perspectives of people recently diagnosed with dementia and their carers
  41. Handwriting patterns in Isolated Rapid Eye Movement Sleep Behaviour Disorder
  42. Mild Cognitive Impairment: Far from “Mild,” but Is Deep Brain Stimulation the Solution?
  43. Computer Vision in Clinical Neurology
  44. Feasibility of computerized motor, cognitive and speech tests in the home: Analysis of TAS Test in 2,300 older adults
  45. Falls in people with Alzheimer’s Disease: Exploring the role of inhibitory control
  46. Chronic Pain in Parkinson’s Disease: Prevalence, Sex Differences, Regional Anatomy and Comorbidities
  47. Development of a diagnostic checklist to identify functional cognitive disorder versus other neurocognitive disorders
  48. Developing, implementing, and evaluating the first national Memory and Cognition Clinic Guidelines in Australia
  49. ISLAND Campus: a fee-free formal university educational intervention in mid- to later-life to reduce modifiable risk factors for dementia and improve cognition
  50. Associations Between Brain Structure and Dual Decline in Gait and Cognition
  51. Immediate post‐diagnostic support for people with dementia and thier care partners: Scoping literature review
  52. Impact of free later life formal university education on longitudinal modifiable risk factors, cognition and plasma phosphorylated tau 181
  53. Rural‐urban improvements in modifiable risk factors across Tasmania from an online, public health dementia risk reduction initiative: data from ISLAND (Island Study Linking Ageing and Neurodegenerative Disease)
  54. Tapping into a new hand‐motor biomarker of the dementia continuum ‐ integration and validation in a cognitive clinic
  55. Unsupervised online reaction time test improves estimation of cognitive function in a large sample of cognitively‐asymptomatic older adults
  56. Using TAS Test online hand‐tapping tests to detect cognitive decline in a large community cohort of older Australians
  57. Chronic Musculoskeletal Pain and Risk of Incident Parkinson's Disease: A 13‐Year Longitudinal Study
  58. Validation of computer vision technology for analyzing bradykinesia in outpatient clinic videos of people with Parkinson's disease
  59. Associations between brain structure and dual decline in gait and cognition
  60. P027 Dream characteristics are sex-specific in REM Sleep Behaviour Disorder and healthy older adults
  61. Smartphone automated motor and speech analysis for early detection of Alzheimer's disease and Parkinson's disease: Validation of TapTalk across 20 different devices
  62. Practical Ultrasound
  63. Deep learning of Parkinson's movement from video, without human-defined measures
  64. Hand Motor Dysfunction Is Associated with Both Subjective and Objective Cognitive Impairment across the Dementia Continuum
  65. Validation and application of computer vision algorithms for video-based tremor analysis
  66. The Parkinson's Puzzle Box
  67. Widening the Phenotype of Fragile‐X Tremor Ataxia Syndrome in Females: Spasmodic Dysphonia in Two Patients
  68. Perspectives on the diagnosis and management of functional cognitive disorder: An international Delphi study
  69. Identifying and Managing Drug Induced Parkinsonism: The Role of Neuroscience Nurses
  70. Development of a smartphone screening test for preclinical Alzheimer’s disease and validation across the dementia continuum
  71. Modifiable dementia risk factors and AT(N) biomarkers: findings from the EPAD cohort
  72. Transdermal Rotigotine at End-of-Life for Parkinson's Disease: Association With Measures of Distress
  73. The effect of dyskinesia on postural control, balance, gait, and fall risk in people with Parkinson’s disease: a systematic review protocol
  74. Brief webcam test of hand movements predicts episodic memory, executive function, and working memory in a community sample of cognitively asymptomatic older adults
  75. Parallel scale de-blur net for sharpening video images for remote clinical assessment of hand movements
  76. Rapid-Motion-Track: Markerless tracking of fast human motion with deep learning
  77. Development of a smartphone screening test for preclinical Alzheimer's disease and validation across the dementia continuum
  78. Visual perceptive deep learning for smartphone video-based tremor analysis: VIPER-Tremor
  79. Clinical validation of TAS Test automated hand motor analysis to discriminate subjective cognitive decline, mild cognitive impairment and dementia in a multidisciplinary cognitive clinic
  80. Clinical validation of TAS Test automated hand motor analysis to discriminate subjective cognitive decline, mild cognitive impairment and dementia in a multidisciplinary cognitive clinic
  81. Identifying preclinical Alzheimer’s disease in the community with brief automated hand movement analysis: validation against plasma ptau181 and asymptomatic episodic memory decline
  82. Identifying preclinical Alzheimer’s disease in the community with brief automated hand movement analysis: validation against plasma ptau181 and asymptomatic episodic memory decline
  83. Isolated REM sleep behaviour disorder in the Tasmanian ISLAND Sleep Study: prevalence and profiles of prodromal dementia
  84. Modifiable dementia risk factor associations with AT(N) biomarkers: Findings from the European Prevention of Alzheimer’s Dementia study
  85. Plasma phosphorylated tau 181 and modifiable risk factors for dementia in a large scale cohort of Australian older adults
  86. Tasmanian ISLAND Sleep Study: prodromal neurodegenerative disease (iRBD) is associated with subjective reports of daytime sleepiness and poor sleep quality
  87. Isolated rapid eye movement sleep behaviour disorder (iRBD) in the Island Study Linking Ageing and Neurodegenerative Disease (ISLAND) Sleep Study: protocol and baseline characteristics
  88. Enhancing post-diagnostic care in Australian memory clinics: Health professionals’ insights into current practices, barriers and facilitators, and desirable support
  89. Brain Networks Involved in Sensory Perception in Parkinson’s Disease: A Scoping Review
  90. Modifiable risk factors for dementia, cognition, and plasma phosphorylated tau 181 in a large-scale cohort of Australian older adults
  91. Current evidence on the association of tongue strength with cognitive decline in older adults and the known risk factors of frailty, sarcopenia and nutritional health: a scoping review protocol
  92. An online, public health framework supporting behaviour change to reduce dementia risk: interim results from the ISLAND study linking ageing and neurodegenerative disease
  93. Pushing through the Barriers: Peer Advice to Increase Physical Activity and Reduce Dementia Risk from Participants in a Massive Open Online Alzheimer's Focused Course
  94. Does serum neurofilament light help predict accelerated cognitive ageing in unimpaired older adults?
  95. 15 TAS test clinical validation: automated hand movement analysis helps discriminate subjective cognitive decline, mild cognitive impairment and dementia
  96. 2692 The future is in our hands: screening for preclinical alzheimer’s disease at home using automated analysis of hand movements
  97. A new one‐stop interdisciplinary cognitive clinic model tackles rural health inequality and halves the time to diagnosis: Benchmarked against a national dementia registry
  98. Estimating presymptomatic episodic memory impairment using simple hand movement tests: A cross‐sectional study of a large sample of older adults
  99. Contactless hand tremor amplitude measurement using smartphones: development and pilot evaluation
  100. Multimodal learning of clinically accessible tests to aid diagnosis of neurodegenerative disorders: a scoping review
  101. Investigating the associations between upper limb motor function and cognitive impairment: a scoping review
  102. Parkinsonian Hand or Clinician’s Eye? Finger Tap Bradykinesia Interrater Reliability for 21 Movement Disorder Experts
  103. Instruments measuring change in cognitive function in multiple sclerosis: A systematic review
  104. Functional neurological disorder is a feminist issue
  105. An online, public health framework supporting behaviour change to reduce dementia risk: interim results from the Island Study Linking Ageing and Neurodegenerative Disease
  106. Sex-Specific Protective Effects of Cognitive Reserve on Age-Related Cognitive Decline
  107. Clinicians' implicit and explicit attitudes about the legitimacy of functional neurological disorders correlate with referral decisions
  108. Of Mice and Pose: 2D Mouse Pose Estimation from Unlabelled Data and Synthetic Prior
  109. REM sleep behaviour disorder: the importance of early identification in primary care
  110. Real-time automated detection of older adults' hand gestures in home and clinical settings
  111. Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease
  112. Differences in clinical manifestations of late-onset, compared to earlier-onset essential tremor: A scoping review
  113. Moving towards intelligent telemedicine: Computer vision measurement of human movement
  114. The TAS Test project: a prospective longitudinal validation of new online motor-cognitive tests to detect preclinical Alzheimer’s disease and estimate 5-year risks of cognitive decline and dementia
  115. Systemic lupus erythematosus-induced intracranial hypertension: rare but important
  116. Challenges of Incorporating Digital Health Technology Outcomes in a Clinical Trial: Experiences from PD STAT
  117. Geste Antagoniste Effects on Motor Performance in Dystonia—A Kinematic Study
  118. Diagnostic Accuracy of the Overlapping Infinity Loops, Wire Cube, and Clock Drawing Tests in Subjective Cognitive Decline, Mild Cognitive Impairment and Dementia
  119. New horizons in late-onset essential tremor: a pre-cognitive biomarker of dementia?
  120. Isolated REM sleep behaviour disorder: current diagnostic procedures and emerging new technologies
  121. To the emergency room and back again: Circular healthcare pathways for acute functional neurological disorders
  122. 248  Tremor frequency can be measured using smartphone video
  123. Increased Knowledge of Adult-Onset Dystonia Amongst Medical Students via Brief Video Education: A Systematic Review and Cohort Study
  124. Island Study Linking Aging and Neurodegenerative Disease (ISLAND) Targeting Dementia Risk Reduction: Protocol for a Prospective Web-Based Cohort Study
  125. Applications of artificial intelligence to aid early detection of dementia: A scoping review on current capabilities and future directions
  126. Truth, hope and the disclosure of a dementia diagnosis: A scoping review of the ethical considerations from the perspective of the person, carer and clinician
  127. Are tomorrow’s doctors prepared to prevent dementia? A cross-sectional study of Tasmanian medical students’ knowledge of dementia risk factors
  128. Evolutionary Design of Reduced Precision Levodopa-Induced Dyskinesia Classifiers
  129. Automated analysis of propositional idea density in older adults
  130. TasTest: Moving towards a digital screening test for pre‐clinical Alzheimer’s disease
  131. Island Study Linking Aging and Neurodegenerative Disease (ISLAND) Targeting Dementia Risk Reduction: Protocol for a Prospective Web-Based Cohort Study (Preprint)
  132. Parkinson’s disease diagnosis using convolutional neural networks and figure-copying tasks
  133. Association Between Components of Cognitive Reserve and Serum BDNF in Healthy Older Adults
  134. Hand tremor detection in videos with cluttered background using neural network based approaches
  135. Significant cognitive decline in Parkinson's disease exacerbates the reliance on visual feedback during upper limb reaches
  136. Significant cognitive decline in Parkinson’s disease exacerbates the reliance on visual feedback during upper limb reaches
  137. Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit
  138. An Innovative Personalised Management Program for Older Adults with Parkinson’s Disease: New Concepts and Future Directions
  139. Moving Towards Intelligent Telemedicine: Computer Vision Measurement of Human Movement
  140. Studying at university in later life slows cognitive decline: A long‐term prospective study
  141. Accuracy of Smartphone Video for Contactless Measurement of Hand Tremor Frequency
  142. The Island Study Linking Ageing and Neurodegenerative Disease (ISLAND): A longitudinal public health research program targeting dementia risk reduction
  143. Seeing the unseen: Could Eulerian video magnification aid clinician detection of subclinical Parkinson’s tremor?
  144. Supervised classification of bradykinesia in Parkinson’s disease from smartphone videos
  145. What is it like to live with a functional movement disorder? An interpretative phenomenological analysis of illness experiences from symptom onset to post‐diagnosis
  146. The discerning eye of computer vision: Can it measure Parkinson's finger tap bradykinesia?
  147. Get Parkinson’s medications on time: the Leeds QI project
  148. Time series clustering to examine presence of decrement in Parkinson’s finger-tapping bradykinesia
  149. Oromandibular dystonia: a diagnosis not to miss
  150. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson’s disease: a study protocol for a randomised controll...
  151. Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
  152. Can we reduce the risk of dementia with exercise?
  153. 127 Audit of poor response to botulinum toxin in cervical dystonia
  154. Health at the writing desk of John Ruskin: a study of handwriting and illness
  155. Application of classification for figure copying test in Parkinson's disease diagnosis by using cartesian genetic programming
  156. Multiple myeloma with multiple neurological presentations
  157. Computer vision of smartphone video has potential to detect functional tremor
  158. Supervised Classification of Bradykinesia for Parkinson's Disease Diagnosis from Smartphone Videos
  159. Multiple system atrophy mimicked by multi-organ pathology
  160. Inferring the long duration response to levodopa in Parkinson’s disease
  161. FM2-1 A smartphone camera can detect functional tremor
  162. P68 Activation of the geste antagoniste improves speed of finger tapping in organic and functional dystonia
  163. P66 Should we be screening for depression and quality of life in all patients attending botulinum toxin injection clinics or just those with cervical dystonia?
  164. A smartphone camera reveals an ‘invisible’ Parkinsonian tremor: a potential pre-motor biomarker?
  165. WED 109 Computer vision: a smartphone camera can ‘see’ bradykinesia
  166. 292 Mapping patient pathways for acute functional neurological symptoms
  167. WED 112 Seeing invisible parkinsonian tremor with a smartphone camera
  168. Objective assessment of bradykinesia in Parkinson’s disease using evolutionary algorithms: clinical validation
  169. 131A quality improvement project to improve the care of people with Parkinson’s in a large teaching hospitals trust
  170. Cognitive deficits in Parkinson’s disease: current perspectives
  171. Objective Evaluation of Bradykinesia in Parkinson’s Disease using Evolutionary Algorithms
  172. A New Evolutionary Algorithm-Based Home Monitoring Device for Parkinson’s Dyskinesia
  173. How to use pen and paper tasks to aid tremor diagnosis in the clinic
  174. A History of Dystonia: Ancient to Modern
  175. Lesson of the month 1: Subacute thyroiditis: a rare cause of fever of unknown origin
  176. Lesson of the month 2: Transient reversible amnesia in multiple sclerosis
  177. Going through directional changes
  178. Objective Assessment of Cognitive Impairment in Parkinson’s Disease Using Evolutionary Algorithm
  179. Exploring diagnostic models of Parkinson's disease with multi-objective regression
  180. Functional dystonia and the borderland between neurology and psychiatry: New concepts
  181. Dystonia in a prolific medieval scribe
  182. Using epigenetic networks for the analysis of movement associated with levodopa therapy for Parkinson's disease
  183. Study of levodopa response in Parkinson's disease: Observations on rates of motor progression
  184. A Multi-Objective Approach to Predicting Motor and Cognitive Deficit in Parkinson's Disease Patients
  185. Using Multiobjective Evolutionary Algorithms to Understand Parkinson's Disease
  186. What to do when people with Parkinson's disease cannot take their usual oral medications
  187. Computational approaches for understanding the diagnosis and treatment of Parkinson's disease
  188. Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?
  189. Cost Effectiveness Analysis of A Device to Monitor Levodopa-Induced Dyskinesia In Parkinson’s Patients
  190. Reply: Essential tremor in ‘The tremulous hand of Worcester’: additional comments
  191. FINGER TAPPING AND COGNITION IN PARKINSON'S
  192. THE RELATIONSHIP BETWEEN CLOCK DRAWING AND COGNITION IN PARKINSON'S
  193. VISUOSPATIAL TESTS TO SCREEN FOR IMPAIRED COGNITION IN PARKINSON'S
  194. What type of tremor did the medieval ‘Tremulous Hand of Worcester’ have?
  195. When myopathy breaks the rules: a late-onset distal presentation
  196. Cognitive impairment in Parkinson's disease
  197. Evolving Classifiers to Recognize the Movement Characteristics of Parkinson's Disease Patients
  198. Classification and characterisation of movement patterns during levodopa therapy for parkinson's disease
  199. Clinically ‘/INS;slight’/INS; bradykinesia is accurately detected using a novel device that requires a one-minute test period
  200. The sequence effect is not a defining characteristic of Parkinson'/INS;s disease
  201. Practical Ultrasound
  202. Palliative care for Parkinson’s disease: A summary of the evidence and future directions
  203. Characterisation of movement disorder in parkinson's disease using evolutionary algorithms
  204. Characterising neurological time series data using biologically motivated networks of coupled discrete maps
  205. Evolving classifiers to inform clinical assessment of Parkinson's disease
  206. Longitudinal study of levodopa in Parkinson's disease: Effects of the advanced disease phase
  207. 103 Computer assisted diagnosis and monitoring of Parkinson's disease
  208. Evolving Computational Dynamical Systems to Recognise Abnormal Human Motor Function
  209. PO.11 How is stroke thrombolysis affecting neurology training?
  210. A practical guide to the differential diagnosis of tremor
  211. A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease
  212. Longitudinal study of the levodopa motor response in Parkinson's disease: Relationship between cognitive decline and motor function
  213. John Ruskin's relapsing encephalopathy
  214. Multi-system complications of hypothermia: a case of recurrent episodic hypothermia with a review of the pathophysiology of hypothermia
  215. Cluster-like headache secondary to trigeminal meningioma
  216. A patient with neuro-Behçet's disease is successfully treated with etanercept: Further evidence for the value of TNFα blockade
  217. Pulmonary artery dissection: an emerging cardiovascular complication in surviving patients with chronic pulmonary hypertension
  218. Editorial
  219. The well-tempered computer
  220. Dorians and Ionians